Can metoprolol be used safely during pregnancy, and what dosing and monitoring are recommended?

Metoprolol in Pregnancy

Metoprolol can be used during pregnancy for hypertension and cardiac conditions when clinically indicated, though it requires careful monitoring due to dose-dependent fetal growth restriction risks. 1, 2

Safety Profile and Indications

Metoprolol is explicitly recommended by European guidelines as a safe option for treating hypertension during pregnancy 2. The drug is classified as FDA Pregnancy Category C, meaning animal studies show adverse effects but there are no adequate human studies, and it should be used only if clearly needed 3.

Key safety considerations:

• No teratogenic potential demonstrated in animal studies 3
• Animal data shows embryotoxicity/fetotoxicity only at high doses (50 mg/kg in rats, 25 mg/kg in rabbits) 3
• Crosses the placenta and exposes the fetus 3

Fetal Risks: The Dose-Response Relationship

The most significant concern with metoprolol use in pregnancy is dose-dependent intrauterine growth restriction:

• High-dose exposure: 5-fold increased risk of small-for-gestational-age (SGA) infants (adjusted OR 4.89,95% CI 2.22-10.78) 4
• Low-dose exposure: 2-fold increased risk of SGA, though not statistically significant (adjusted OR 1.75,95% CI 0.83-3.72) 4
• Long-term exposure (second/third trimester) resulted in 24.1% SGA rate versus 10.2% with methyldopa and 9.9% in non-hypertensive controls 5

Other neonatal effects include:

• Increased risk of prematurity (OR 2.2 compared to non-hypertensive pregnancies) 5
• Rare neonatal bradycardia, hypoglycemia, and respiratory disorders (11.5% overall adverse outcomes) 5
• Most neonatal symptoms are mild and well-tolerated 5

Dosing and Pharmacokinetic Considerations

Pregnancy dramatically alters metoprolol metabolism, requiring dose adjustments:

• Apparent oral clearance increases significantly during pregnancy 6:
  • Mid-pregnancy: 361 ± 223 L/h
  • Late pregnancy: 568 ± 273 L/h
  • Postpartum: 192-200 ± 98-131 L/h
• This means doses may need to be doubled or tripled during pregnancy to maintain therapeutic effect 6
• Aggressive dose adjustments (both amount and frequency) may be necessary for adequate clinical response 6

Monitoring Requirements

Mandatory monitoring includes:

• Serial fetal growth ultrasounds to detect growth restriction early
• Regular maternal blood pressure monitoring
• Consider therapeutic drug monitoring if available 6
• Close neonatal observation for 48 hours after delivery for bradycardia, hypoglycemia, and respiratory issues 5, 7
• Maternal cardiac monitoring for approximately 48 hours postpartum due to electrolyte/volume shifts 7

Clinical Decision Algorithm

When to use metoprolol:

1. Pre-existing hypertension requiring beta-blocker therapy
2. Cardiac arrhythmias during pregnancy (particularly supraventricular) 7
3. Long QT syndrome in pregnancy 8
4. Peripartum cardiomyopathy management 9

Preferred alternatives in specific situations:

• For simple gestational hypertension: Consider labetalol or nifedipine as first-line 1, 10
• Labetalol has comparable efficacy with potentially better fetal outcomes 2
• Methyldopa showed lower SGA rates (10.2% vs 24.1%) in head-to-head comparison 5

Avoid atenolol: This beta-blocker is specifically associated with significant fetal growth restriction and should not be used 8, 11

Breastfeeding

Metoprolol is safe during breastfeeding 1. Excretion into breast milk is minimal, with an infant consuming 1 liter daily receiving less than 1 mg of the drug 3. Relative infant exposure is <1.0% of maternal weight-adjusted dose 6.

Critical Pitfalls to Avoid

1. Don't assume standard non-pregnancy doses will be adequate - pregnancy increases clearance by 2-3 fold 6
2. Don't use high doses without compelling indication - the 5-fold increased SGA risk with high doses demands careful risk-benefit assessment 4
3. Don't skip fetal growth monitoring - this is the primary adverse outcome and is dose-dependent 4, 5
4. Don't confuse metoprolol safety with atenolol - atenolol has worse fetal outcomes 8, 11
5. Don't discontinue abruptly postpartum - continue monitoring for 48 hours due to hemodynamic shifts 7

Practical Approach

For women already on metoprolol who become pregnant:

• Continue therapy if clinically indicated (benefits outweigh risks) 2
• Use the lowest effective dose possible 4, 11
• Establish baseline fetal growth parameters early
• Plan serial growth ultrasounds every 3-4 weeks in third trimester
• Prepare neonatal team for potential monitoring needs

For new-onset hypertension in pregnancy:

• Consider labetalol or nifedipine as first-line unless specific contraindications 1, 10
• Reserve metoprolol for cases where other agents fail or specific cardiac indications exist
• If metoprolol is chosen, start with lowest effective dose and titrate carefully

The evidence demonstrates that while metoprolol can be used safely in pregnancy with appropriate monitoring, the dose-dependent fetal growth restriction risk requires careful consideration of alternatives and vigilant surveillance when this agent is selected 4, 5, 11.